Literature DB >> 10362189

A comparison of the national registry of myocardial infarction 2 with the cooperative cardiovascular project.

N R Every1, P D Frederick, M Robinson, J Sugarman, L Bowlby, H V Barron.   

Abstract

OBJECTIVES: This study was performed to evaluate whether or not the simpler case identification and data abstraction processes used in National Registry of Myocardial Infarction two (NRMI 2) are comparable with the more rigorous processes utilized in the Cooperative Cardiovascular Project (CCP).
BACKGROUND: The increased demand for quality of care and outcomes data in hospitalized patients has resulted in a proliferation of databases of varying quality. For patients admitted with myocardial infarction, there are two national databases that attempt to capture critical process and outcome data using different case identification and abstraction processes.
METHODS: We compared case ascertainment and data elements collected in Medicare-eligible patients included in the industry-sponsored NRMI 2 with Medicare enrollees included in the Health Care Financing Administration-sponsored CCP who were admitted during identical enrollment periods. Internal and external validity of NRMI 2 was defined using the CCP as the "gold standard."
RESULTS: Demographic and procedure use data obtained independently in each database were nearly identical. There was a tendency for NRMI 2 to identify past medical histories such as prior infarct (29% vs. 31%, p < 0.001) or heart failure (21% vs. 25%, p < 0.001) less frequently than the CCP. Hospital mortality was calculated to be higher in NRMI 2 (19.7% vs. 18.1%, p < 0.001) due mostly to the inclusion of noninsured patients 65 years and older in NRMI 2.
CONCLUSIONS: We conclude that the simpler case ascertainment and data collection strategies employed by NRMI 2 result in process and outcome measures that are comparable to the more rigorous methods utilized by the CCP. Outcomes that are more difficult to measure from retrospective chart review such as stroke and recurrent myocardial infarction must be interpreted cautiously.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362189     DOI: 10.1016/s0735-1097(99)00113-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  17 in total

Review 1.  Global registries for measuring pharmacoeconomic and quality-of-life outcomes: focus on design and data collection, analysis and interpretation.

Authors:  Lisa Kennedy; Ann-Marie Craig
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Acute reperfusion therapy in ST-elevation myocardial infarction from 1994-2003.

Authors:  Brahmajee K Nallamothu; Martha E Blaney; Susan M Morris; Lori Parsons; Dave P Miller; John G Canto; Hal V Barron; Harlan M Krumholz
Journal:  Am J Med       Date:  2007-08       Impact factor: 4.965

3.  Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction.

Authors:  John G Canto; Catarina I Kiefe; William J Rogers; Eric D Peterson; Paul D Frederick; William J French; C Michael Gibson; Charles V Pollack; Joseph P Ornato; Robert J Zalenski; Jan Penney; Alan J Tiefenbrunn; Philip Greenland
Journal:  JAMA       Date:  2011-11-16       Impact factor: 56.272

4.  Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002.

Authors:  Viola Vaccarino; Saif S Rathore; Nanette K Wenger; Paul D Frederick; Jerome L Abramson; Hal V Barron; Ajay Manhapra; Susmita Mallik; Harlan M Krumholz
Journal:  N Engl J Med       Date:  2005-08-18       Impact factor: 91.245

5.  The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction.

Authors:  K P Champney; P D Frederick; H Bueno; S Parashar; J Foody; C N B Merz; J G Canto; J H Lichtman; V Vaccarino
Journal:  Heart       Date:  2009-01-15       Impact factor: 5.994

6.  Atherosclerotic risk factors and their association with hospital mortality among patients with first myocardial infarction (from the National Registry of Myocardial Infarction).

Authors:  John G Canto; Catarina I Kiefe; William J Rogers; Eric D Peterson; Paul D Frederick; William J French; C Michael Gibson; Charles V Pollack; Joseph P Ornato; Robert J Zalenski; Jan Penney; Alan J Tiefenbrunn; Philip Greenland
Journal:  Am J Cardiol       Date:  2012-07-27       Impact factor: 2.778

7.  Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction.

Authors:  Robert L McNamara; Jeph Herrin; Yongfei Wang; Jeptha P Curtis; Elizabeth H Bradley; David J Magid; Saif S Rathore; Brahmajee K Nallamothu; Eric D Peterson; Martha E Blaney; Paul Frederick; Harlan M Krumholz
Journal:  Am J Cardiol       Date:  2007-08-01       Impact factor: 2.778

8.  Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction.

Authors:  Henry H Ting; Elizabeth H Bradley; Yongfei Wang; Judith H Lichtman; Brahmajee K Nallamothu; Mark D Sullivan; Bernard J Gersh; Veronique L Roger; Jeptha P Curtis; Harlan M Krumholz
Journal:  Arch Intern Med       Date:  2008-05-12

9.  Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006.

Authors:  Viola Vaccarino; Lori Parsons; Eric D Peterson; William J Rogers; Catarina I Kiefe; John Canto
Journal:  Arch Intern Med       Date:  2009-10-26

10.  The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China.

Authors:  Andrew Moran; Dong Zhao; Dongfeng Gu; Pamela Coxson; Chung-Shiuan Chen; Jun Cheng; Jing Liu; Jiang He; Lee Goldman
Journal:  BMC Public Health       Date:  2008-11-27       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.